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Successful expansion of hematopoietic stem cells (HSCs) would benefit the use of HSC transplants in the clinic.
Angiopoietin-like 7 promotes the expansion of hematopoietic stem and progenitor cells (HSPC) in vitro and
ex vivo. However, the impact of loss of Angptl7 on HSPCs in vivo has not been characterized. Here, we generated
Angptl7-deficient mice by TALEN-mediated gene targeting and found that HSC compartments in Angptl7-null mice
were compromised. In addition, wild type (WT) HSPCs failed to repopulate in the BM of Angptl7-null mice after serial
transplantations while the engraftment of Angptl7-deficient HSPCs in WT mice was not impaired. These results
suggest that Angptl7 is required for HSPCs repopulation in a non-cell autonomous manner.
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The autologous-allogeneic hematopoietic cell transplant-
ation has been developed for decades [1,2], and numerous
attempts have been made to expand the HSCs population
in vitro and in vivo [3-5]. Agiopoietin-like proteins belong
to a 7-member family of secreted glycoproteins that share
sequence homology with angiopoietins, which are import-
ant modulators of angiogenesis [6]. Several Angptl family
proteins promote the expansion of murine and human
HSPCs in vitro and ex vivo [7-9]. Angptl7 in the ECM of
the trabecular meshwork plays an important role in the
deposition and organization of the matrix of the outflow
tissue [10]. Recently, we found that ANGPTL7 stimulated
the proliferation of human HSPCs ex vivo (Yiren Xiao, un-
published data). In addition, we uncovered that Angptl7,* Correspondence: pei_duanqing@gibh.ac.cn; li_peng@gibh.ac.cn
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enchymal cells (Additional file 1: Figure S1), stimulated ex-
pansion of murine HSCs ex vivo (Additional file 2: Figure
S2). However, whether Angptl7 is redundant and dispens-
able or not for repopulation of HSPCs in vivo remains un-
known. In this study, we generated Angptl7 knockout mice
and revealed that Angptl7 is essential for HSPC repopula-
tion in a non-cell autonomous way.
To investigate whether the loss of Angptl7 affected
HSPCs in vivo, we generated Angptl7-null mice by
TALEN-mediated gene targeting (Additional file 1:
Figure S1a-1c). The procedures of gene targeting were de-
scribed in (Additional file 3: Supplementary methods) and
(Additional file 4: Table S1). Loss of Angptl7 in Angptl7-
null mice was confirmed in the bone marrow (BM) by
RT-PCR and Western blotting (Additional file 5: Figure
S3d-3e). The Angptl7-null mice did not display an overt
phenotype. There were no significant differences in ei-
ther birth weights or adult weights among Angptl7−/−,
Angptl7+/−, and Angptl7+/+ mice (Additional file 6:
Table S2). In addition, we found no significant differ-
ences in staining profiles T cells, B cells, myeloid cells,
and erythroid cells among the Angptl7−/−, Angptl7+/−
and Angptl7+/+ mice (Figure 1a).is is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Reduced HSC in Angptl7−/− mice. (a) Characterization of multiple hematopoietic lineages in BM. The major lineages of hematopoietic
cells in BM in Angptl7−/− Angptl7+/− and Angptl7+/+ mice were quantitated by flow cytometry analysis as erythroid cells (Ter119), myeloid cells
(Ly6g and CD11b), T cells (CD3e) and B cells (CD19). Data represent the means +/− s.e.m (n = 5 for each group). (b, c) Comparison of the
frequencies (b) and number (c) of Lin-Mac-1 + CD4- population in the fetal liver of Angptl7−/− Angptl7+/− and Angptl7+/+ mice. Data represent the
means +/− s.e.m (n = 10 for each group). *P < 0.05 versus Angptl7−/− group for Angptl7+/− and Angptl7+/+. (d, e) Comparison of the frequencies
(d) and number (e) of LSK population in the BM of Angptl7−/− Angptl7+/− and Angptl7+/+ mice. Data represent the means +/− s.e.m (n = 6 for each
group). *P < 0.05 versus Angptl7−/− group for Angptl7+/− and Angptl7+/+ group. (f, g) Comparison of the frequencies (left) and number (right) of
LT-HSCs in the BM of Angptl7−/− Angptl7+/− and Angptl7+/+ mice. Data represent the means +/− s.e.m (n = 5 for each group). *P < 0.05 versus
Angptl7−/− group for Angptl7+/− and Angptl7+/+ group. (h) The colony numbers of CFU assays obtained from BM of Angptl7−/− Angptl7+/− and
Angptl7+/+ mice. Data represent the means +/− s.e.m (n = 3). *P < 0.05 versus bar 7 for bar 9.
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during embryo development [11-13], we examined the
fetal liver HSC compartment and found that the per-
centages and numbers of Lin-Mac-1 + CD4- population,
which was highly enriched of HSCs in fetal liver [14,15],
were significantly lower in the fetal livers of Angptl7−/−
mice than that in Angptl7+/− and Angptl7+/+ mice
(Figure 1b-c). In addition, we found the percentages
and numbers of Lin-Sca-1 + c-Kit + (LSK) population
in the BM of adult Angptl7−/− mice were significantlylower than that in Angptl7+/− and Angptl7+/+ mice
(Figure 1d-e). Further analysis showed that Angptl7−/−
mice had fewer long-term HSCs (Lin−Sca-1+Kit+Flk2−
CD34−) than Angptl7+/− and Angptl7+/+ mice (Figure
1f-g). Cloning forming assay results showed that BM cells
from Angptl7−/− mice had fewer granulocyte/monocyte
progenitors (CFU-GM), but similar numbers of erythroid
precursors (CFU-E/BFU-E) and hematopoietic progenitors
(CFU-GEMM) than WT BM (Figure 1h). Therefore,
Angptl7-deficient BM had normal levels of terminally
Figure 2 (See legend on next page.)
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Figure 2 Comparison of reconstitution capacity of HSC in Angptl7−/− Angptl7+/− and Angptl7+/+ mice. (a) Experimental design for
assessing the repopulation efficiency in Angptl7-null BM environment. (b) Comparison of the repopulation efficiency in BM of Angptl7−/− Angptl7+/−
and Angptl7+/+ recipients. Data represent the means +/− s.e.m. (n = 8 for each group). (c, d) Comparison of the frequencies (c) and number (d) of
LT-HSCs in BM of Angptl7−/− Angptl7+/− and Angptl7+/+ recipients. Data represent the means +/− s.e.m. (n = 8 for each group). *P≤ 0.05 for bar 9 versus
bar 7 and bar 8. (e) Comparison of the second transplantation repopulation efficiency in BM of Angptl7−/− Angptl7+/− and Angptl7+/+ recipients as
referred in (a). Data represent the means +/− s.e.m (n= 7 for each group). *P≤ 0.05 for bar 6 versus bar 4 and bar 5, for bar 9 versus bar 7 and bar 8,
for bar 12 versus bar 10 and bar 11. (f) Experimental design effect of endogenous deletion of Angptl7 in HSCs. Angptl7−/− Angptl7+/− or Angptl7+/+
donor BM CD45.2 cells (5x105 cells) were transplanted into lethally irradiated WT CD45.1 recipient mice. (g) Comparison of the repopulation efficiency
of donor BM Angptl7−/− Angptl7+/− and Angptl7+/+cells. Data represent the means +/− s.e.m. (n= 8 for each group). (h, i) Comparison of the frequencies
(h) and number (i) of donor Angptl7−/− Angptl7+/− and Angptl7+/+ LT-HSCs in BM of WT recipients. Data represent the means +/− s.e.m. (n = 8 for each
group). (j) Comparison of the repopulation efficiency of Angptl7−/− Angptl7+/− and Angptl7+/+ donor BM cells in second recipients mice as described
in (f). Data represent the means +/− s.e.m (n = 8 for each group).
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progenitors. To investigate whether other angiopoietin-
like proteins compensate the loss of Angptl7 in BM, we
compared the expression levels of other angiopoietin-like
proteins in Angptl7-deficient BM stromal cells to that in
WT BM stromal cells and found that their expression
levels did not significantly change due to loss of Angptl7
(Additional file 7: Figure S4).
Since Angptl7 is secreted by stromal cells and binds to
HSPCs [9], we speculated that Angptl7 may play a non-cell
autonomous role in reconstitution of the hematopoietic
system. To evaluate the hypothesis, we compared the
extent of repopulation of HSCs in Angptl7−/−, Angptl7+/−
and Angptl7+/+ recipient mice. After WT donor BM cells
were injected into lethally irradiated Angptl7−/− Angptl7+/−
or Angptl7+/+ recipients without competitors (Figure 2a),
we found that the reconstitution efficiencies of HSCs were
similar among Angptl7−/−, Angptl7+/− and WT recipi-
ent mice (Figure 2b), but the frequencies and numbers
of LT-HSCs in Angptl7−/− recipients were significantly
lower than that in Angptl7+/− and WT recipients, sug-
gesting that Angptl7 supports the maintenance of the
HSC pool in BM (Figure 2c-d). Continuously the BM
cells from the primarily repopulated Angptl7−/−,
Angptl7+/− and WT recipient mice were collected for
secondary transplantation. We found that the repopu-
lating activity of cells originating from the primary
Angptl7−/− recipients was significantly decreased com-
pared with those from the primary Angptl7+/− and WT
recipients at different time points (Figure 2e). To test
whether Angptl7 had a cell-intrinsic effect on HSCs,
we transplanted Angptl7−/−, Angptl7+/− or WT BM
cells into lethally irradiated WT recipients and mea-
sured the frequencies of donor cells in recipient mice
(Figure 2f). We found the repopulation efficiencies, per-
centages, and numbers of donor Angptl7−/−, Angptl7+/−
and WT LT-HSCs were similar in WT recipients
(Figure 2g-i). We further transplanted the BM cells
from the primary recipient mice to lethally irradiated WT
mice. The repopulation efficiencies of secondary trans-
plantation were similar among Angptl7−/−, Angptl7+/− andWT donors at indicated time points (Figure 2j). Overall,
these results suggest that Angptl7 promoted HSC repopu-
lation in a non-cell autonomous manner in vivo.
In this study, we demonstrated that deficiency of
Angptl7 in the BM niche as a lack of exogenous Angptl7
stimulation impaired the reconstitution of HSCs in le-
thally irradiated mice, whereas endogenous deletion of
Angptl7 in HSCs did not affect repopulation of HSCs in
lethally irradiated mice. Thus, Angptl7 was indispensable
for BM microenvironment to support HSC repopulation.
Additional files
Additional file 1: Figure S1. Generation of Angptl7 knockout mice. (A)
Angptl7 is highly expressed in BM CD45-SSEA4+ cells. BM cells were
collected by flow cytometry and Angptl7 expression was measured by
real-time RT-PCR. All the cells sorted for analysis were gated from the
CD45- fraction. The results were normalized to β-actin mRNA levels and
represent the means +/- s.e.m. *P < 0.05 versus bar 13 for bar 14. (B)
Fluorescent microscopy imaging analyzes Angptl7 (green) and SEEA4 (red)
cells in mouse BM cells. Nuclei were counterstained with DAPI (blue).
Additional file 2: Figure S2. Treatment with Angptl7 induces the
expansion of mouse HSPC. Left, Representative flow cytometric analysis
of peripheral blood (PB) donor-derived CD45.1+ engraftment at 12 weeks
after transplantation in mice transplanted with the progeny of 1× 105
bone marrow lin- cells after 7 days culture with TSF or TSF plus 500 ng ml−1
Angptl7. Right, The mean levels of donor CD45.1+ cells in the PB of CD45.2
+ recipient mice at 12 weeks after transplantation of CD45.1+ bone marrow
Lin− cells (1 × 105) or their progeny after 7 d of culture with TSF or TSF plus
500 ng ml−1 Angptl7. Data represent the means +/- s.e.m (n = 6 mice per
group ). *P < 0.05 versus bar 2 and bar 3 for bar 1, bar 2 for bar 3.
Additional file 3: Supplemental methods.
Additional file 4: Table S1. Primer list used in generation of Angptl7-
deficient mice.
Additional file 5: Figure S3. (a) Top, the DNA sequences of Angptl7
locus targeted by Angptl7-TALENs are shown. The DNA-binding sites are
in red, and the sequence between the DNA-binding sites is spacer region
blue. There is a restriction site for the endonuclease DraIII between the
two binding sites (blue). Bottom, schematic view of the design of TALENs
targeting the Angptl7 locus. The Angptl7 donor vector contains two
homologous arms on both sides of exon 1 of Angptl7, a splice acceptor,
encoding cDNA of Venus, and puromycin (Puro) that was driven by PGK
promoter. Angptl7-TALEN recognition sites (purple box), SD: splice donor,
SA: splice acceptor. (b) Electropherograms around the TALEN spacer in
the Angptl7 locus. The red boxes highlight the mice identified with
Angptl7 mutations. (c) DNA sequences of the Angptl7 locus from live F0
mice identified in (b). ‘-’ represent deleted nucleotides. (d) The lack of
Angptl7 in the BMs of Angptl7 knockout mice was confirmed by RT-PCR. (e)
Xiao et al. Journal of Hematology & Oncology  (2015) 8:7 Page 5 of 5The lack of Angptl7 in the BMs of Angptl7 knockout mice was confirmed by
western blots.
Additional file 6: Table S2. The organ weight of Angptl7-deficient mice.
Additional file 7: Figure S4. Relative expression levels of angiopoietin-like
proteins in WT (+/+) and Angptl7-/-bone marrow stromal cells. The results
were normalized to β-actin mRNA levels and represent the means +/- s.e.m.
*P< 0.05 versus bar 11 for bar 12.
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